For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...
Please provide your email address to receive an email when new articles are posted on . Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with ...
Intra-arterial (IA) alteplase was associated with superior 90-day functional outcomes than standard therapy alone in Chinese patients with large-vessel occlusion (LVO) stroke who had achieved ...
Just a month after trial results appeared to dampen prospects for the use of intra-arterial thrombolysis on top of stroke thrombectomy in patients with large-vessel occlusions (LVOs), two new trials ...
Two randomized trials found that intra-arterial urokinase and tenecteplase did not improve functional outcomes after mechanical thrombectomy in selected stroke patients. However, these results do not ...
MIAMI & LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, RenovoTAMP ...
Intra-arterial thrombolysis with urokinase or tenecteplase after successful endovascular thrombectomy (EVT) did not significantly improve outcomes in patients with acute ischemic stroke, according to ...
Using inter-arterial chemotherapy compared to intravenous chemotherapy may significantly improve globe salvage rates in children with advanced unilateral retinoblastoma. Intra-arterial chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results